Pages

Jun 28, 2012

This research service is an overview of the global automotive industry. It gives a snapshot of the top 10 companies in the industry in 2010 by sales and what their visions are for the future. It gives the overall production trends with respect to region and global traditional segmentation. It also provides a comparison of financial assessment of developed market OEMs and emerging market OEMs on the parameters of trading multiples, liquidity, margins, and profitability. A brief overview of the transaction trends in the industry is also analyzed as to which financing option is preferred over the years.

2012 Deep Research Report on Global and China PV Ribbon Industry is a professional and in-depth research report on Global and China PV Ribbon industry. This report has firstly introduced PV Ribbon definition classification industry chain etc related information. Then introduced PV Ribbon manufacturing technology analysis, And then summary statistics of Global and China major PV Ribbon manufacturers 2009-2016 PV Ribbon capacity production supply demand shortage and PV Ribbon selling price cost profit margin and production value, and also introduced global regional pv ribbon production market share, Different Coating Materials Manual or Machine Welding Interconnect or Bus Ribbon production market share and supply demand shortage etc information, and then introduced International 11 and China 26 major PV Ribbon Companies basic information, 2009-2016 PV Ribbon capacity production price cost profit margin and production value etc details information. In the end, this report introduced 500tons PV Ribbon project feasibility analysis and investment return analysis, also give related research conclusions and development trend analysis of global and China PV Ribbon industry. In a word, it was a depth research report on global and China PV Ribbon industry. And thanks to the support and assistance from PV Ribbon industry chain manufacturers and government related agencies etc related experts and enterprises during QYResearch Team survey and interview.

The milk and cream market analyses give an overview of the actual situation, trends and future outlook of the milk and cream markets in different Eastern European countries. The market analyses provide essential market information for decision-makers including:

Factors such as South Korea’s developing economy and easing of restrictions on movement are both supporting the growth of travel and tourism in South Korea. South Korea is one of the most attractive countries for inbound and outbound tourism businesses in the world. The country was the seventh-largest inbound tourism destination by volume in the Asia-Pacific region in 2011. Rising tourist volumes and subsequent growth in the South Korean travel intermediaries industry can be attributed to various drivers including the country’s robust economic growth, government initiatives to promote tourism and tourism-related activities, increasing volume of business activities, and high internet penetration that encourages the growth of buying travel and tourism services online.

Scope

This report provides an extensive analysis of the travel intermediaries industry in South Korea

It provides historical and forecast market sizes for the South Korean travel intermediaries industry

It offers detailed analysis of the factors driving the growth of the travel intermediaries industry in South Korea including demand drivers such as total tourist volume, tourist volume by type, spending patterns of domestic and international tourists and internet penetration

The report details the government regulatory frameworks in the South Korean travel intermediaries industry, market entry routes adopted by international travel companies to enter the South Korean market and the expansion strategies of local and international travel companies

The report also offers marketing strategies adopted by the large travel intermediaries in the South Korean market to attract and retain customers

It provides examples of key travel intermediaries companies operating in the South Korean market

Finally, the report also covers 300sets/year 1.5MW Wind Turbine Tower project Feasibility analysis and related research conclusions. In a word, it is a deep research report on Global and China Wind Turbine Tower industry. And thanks to the support and assistance from Wind Turbine Tower industry chain related experts and enterprises during QYResearch Wind Energy Team survey and interview.

The Swedish economy recovered quickly from the recession of 2008/2009 and in 2011 the Swedish economy continued to show strong growth rates in 2011. In the later part of 2011, however the first signs of a cooling down of the economy started to appear and many retailers reported slower than expected sales. The economic instability in many European countries made the Swedish consumers to become more cautious in their spending habits and many started to trade down to cheaper options. How sales are developing in 2012 is highly dependent on how quickly the consumer confidence can be regained.

Natural and organic continues remains the leading trend in 2011

In 2011 the natural and organic trend continued to be one of the strongest trends. The increased demand for natural and organic products can mainly be explained by health concerns and products made from, for example, certified organic ingredients, which are perceived as being healthier than products made from synthetic ingredients. Many consumers who have become allergic to products such as fragrances are turning to organic products which use scents made from essential oils. The awareness that a large amount of products applied to the skin are actually absorbed by the body is also on the rise. A growing number of consumers are also turning to organic products due to environmental concerns, although health concerns represent a strong reason.

Beauty and personal care products is concentrated to a relatively few leading international companies which own a large number of brands. The leading beauty and personal care players are, however, increasingly challenged by retailers launching private label products. Growing demand for natural and certified organic products has also benefited smaller companies which produce niche products for environmentally and health aware consumers. The major beauty and personal care companies can, however, take advantage of the growing demand for private label products and organic products by launching new brands specialising in either budget products of, for example, certified organic products.

Internet retailing continues to take shares

Although Internet sales of beauty and personal care products is still relatively small compared with other channel types, the importance of Internet retailing is growing rapidly. The popularity of Internet retailing can be explained by the fact that Swedes live increasingly hectic lifestyles. Product availability is broader and online stores make it increasingly easy for consumers to shop around for the best prices. On the other hand, Internet retailing is challenged by the fact that it is more difficult to test products before buying – something which can be solved by offering free samples. Online shops requires large investment and especially smaller online stores have difficulty competing against the major players, as delivery costs mean that consumers prefer stores where they can obtain all the products they require.

Sales projected to be weaker over forecast periodThe forecast period CAGR is projected to be weaker than that seen over the review period. Although the Swedish economy has recovered quickly from the recession of 2008/2009, several factors may hamper Swedish consumption over the forecast period. A prolonged instability in important export countries in Europe is not only deterring exports but also affecting the consumer confidence in Sweden. Swedes have for a long time enjoyed rising housing prices and the economic downturn of 2008/2009 did not significantly affect this. There are, however, several warning signs that the housing market in Sweden is overvalued and that a correction in the prices may come during the forecast period – something which would also negatively affect consumption of goods such as beauty and personal care products

The Chilean personal accident and health insurance segment recorded strong growth in gross written premiums during the review period (2007–2011). This growth was driven by the country’s implementation of compulsory personal accident insurance, the rising health awareness among consumers and the increasing volume of outbound tourists from Chile. The country’s stable macroeconomic environment is expected to drive the growth of personal accident and health insurance over the forecast period. In addition, the segment will benefit from the country’s increasing consumer healthcare expenditure, obligatory personal accident insurance and favorable regulatory framework.

Scope

This report provides a comprehensive analysis of the personal accident and health insurance market in Chile:

It provides historical values for the Chilean personal accident and health insurance market for the review period (2007–2011) and forecast period (2012–2016)

It offers a detailed analysis of the key sub-segments in the Chilean personal accident and health insurance market, along with market forecasts until 2016

It covers an exhaustive list of parameters, including written premium, incurred loss, loss ratio, commissions and expenses, combined ratio, frauds and crimes, total assets, total investment income and retentions

It analyses the various distribution channels for personal accident and health insurance products in Chile

Using Porter’s industry-standard “Five Forces” analysis, it details the competitive landscape in Chile for the personal accident and health insurance business

It provides a detailed analysis of the reinsurance market in Chile and its growth prospects

It profiles the top personal accident and health insurance companies in Chile and outlines the key regulations affecting them

The steady growth in GDP and annual disposable income levels in Chile supported the expansion of the country’s personal accident and health insurance segment during the review period.

The country’s improving health awareness and increasing annual disposable income will together encourage more citizens to purchase personal accident and health insurance products over the forecast period.

Changing lifestyle patterns and improving health awareness among the Chilean population is encouraging more healthcare expenditure among citizens in the country. The demand for travel insurance in Chile has increased due to the rising volume of outbound tourists in the country.

The SVS made personal accident insurance mandatory for all motor owners, who must purchase obligatory insurance at the same time as they acquire vehicle registration.

Metlife Chile Seguros de Vida SA is the leading foreign insurer in Latin America, and is providing tough competition to the dominant local insurers in the country. The other leading Chilean personal accident and health insurance companies include BICE Vida, EuroAmerica, Cardif, BCI Vida, Security Vida, Santander, Sura, Cruz del Sur and ACE Seguros de Vida.

Reasons to buy

Make strategic business decisions using in depth historic and forecast market data related to the Chilean personal accident and health insurance market and each sector within it

The Colombian non-life insurance segment demonstrated strong growth during the review period. This was largely generated from the impressive growth of the motor insurance category, which benefited from the country’s rising automobile sales and compulsory third-party liability motor insurance. The Colombian government is planning to triple its current investment on infrastructure by 2014. This investment will be spent on developing roads, buildings, energy and transportation, and will provide opportunities for commercial property and motor insurance providers to capitalize on over the forecast period.

ScopeThis report provides a comprehensive analysis of the non-life insurance market in Colombia:

It provides historical values for the Colombian non-life insurance market for the report’s 2007–2011 review period and forecast figures for the 2012–2016 forecast period

It offers a detailed analysis of the key sub-segments in the Colombian non-life insurance market, along with market forecasts until 2016

It covers an exhaustive list of parameters, including written premium, incurred loss, loss ratio, commissions and expenses, combined ratio, frauds and crimes, total assets, total investment income and retentions

It analyses the various distribution channels for non-life insurance products in Colombia

Using Porter’s industry-standard “Five Forces” analysis, it details the competitive landscape in Colombia for the non-life insurance business

It provides a detailed analysis of the reinsurance market in Colombia and its growth prospects

It profiles the top non-life insurance companies in Colombia and outlines the key regulations affecting them

Infrastructure development is essential for Colombia’s economic growth. This has been identified by the country’s government and, as a result, the government increased its focus on infrastructure development during the review period.

The rising level of non-life insurance fraud and crimes, especially in the motor insurance category, has constrained the growth of the insurance segment. The problem of insurance fraud is considered to be much greater in Colombia than in other South American countries.

The main reason for the large size of the motor insurance category is the country’s robust automobile industry performance and compulsory nature of motor third-party liability insurance. The demand for automobiles increased as Colombians registered rising disposable income levels, some of which was spent on automobiles.

Despite these opportunities for growth, there are a few challenges that could adversely affect Colombian non-life insurance development.

The Colombian insurance industry is one of the largest in Latin America and it contains both domestic and foreign insurers. In 2011, 25 companies were licensed to conduct non-life insurance business operations in Colombia.

Reasons to buy

Make strategic business decisions using in depth historic and forecast market data related to the Colombian non-life insurance market and each sector within it

This BCC market research report provides a detailed overview and thorough analysis of the present and future global market for breast cancer diagnostics and drug technologies. It provides detailed analysis of the breast cancer drug and diagnostics markets, as well as the currently used personalized, predictive and companion tests and their markets. The research also includes market characterization, opportunities, the unmet needs associated with breast cancer, competitive assessment, product profiles of major marketed products and promising drugs in the pipeline, an overview on discontinued projects, implications for future market competition and the key players of the breast cancer market.

This report includes products in this market and detailed analyses of markets and competitive environments. It also analyzes current and future market prospects. It provides a comprehensive review of emerging breast cancer personalized and predictive diagnostic tests, particularly with regard to companion tests, tumor markers and gene profiling assays relevant for breast cancer prognosis and diagnosis. The analysis reviews technological developments, product innovations and recent strategic industry activity of major players across different product categories. It analyzes their strengths and weaknesses, opportunities and threats facing various devices and drugs in this market space and developments already on the market. It discusses the major issues involved in the research and development (R&D) of more effective devices for drug delivery to the lungs, along with new products in development.

REASONS FOR DOING THE STUDY

According to the National Cancer Institute, more than 200,000 women in the U.S. are diagnosed with breast cancer annually. It is no longer necessary for one breast cancer treatment to fit all cases, a concept that should be welcome news for physicians and their patients alike. Personalized medicine is relatively new to the market research report format, and it provides business tools to evaluate new commercial opportunities in diagnostics and biomarker fields. The scope of this report covers global companies developing tests relevant for breast cancer prognosis and diagnosis. This study describes current products in each area, identifies current market participants, and most importantly, notes the trends that will affect further product development in this area.

Companion diagnostics is also a part of the personalized medicine revolution. The field evolved as a continuation of biomarker studies and diagnostics testing. The breast cancer predictive testing segment of the industry is still growing; it has a number of successful FDA–approved products. This study will provide knowledge of the current state of the companion diagnostics industry and the new technologies in assay development. More importantly, it will describe potential and novel commercial developments in this area. The report will also provide an overview covering major biotechnology and pharma companies involved in developing innovative, targeted breast cancer treatments that address major unmet medical needs to advance cancer care. In addition, the report also provides information regarding the less-developed sectors of this market and presents a list of current companies that have new predictive testing products and drugs in development for breast cancer.

According to the National Cancer Institute, more than 200,000 women in the U.S. are diagnosed with breast cancer annually. It is no longer necessary for one breast cancer treatment to fit all cases, a concept that should be welcome news for physicians and their patients alike. Personalized medicine is relatively new to the market research report format, and it provides business tools to evaluate new commercial opportunities in diagnostics and biomarker fields. The scope of this report covers global companies developing tests relevant for breast cancer prognosis and diagnosis. This study describes current products in each area, identifies current market participants, and most importantly, notes the trends that will affect further product development in this area.

Companion diagnostics is also a part of the personalized medicine revolution. The field evolved as a continuation of biomarker studies and diagnostics testing. The breast cancer predictive testing segment of the industry is still growing; it has a number of successful FDA–approved products. This study will provide knowledge of the current state of the companion diagnostics industry and the new technologies in assay development. More importantly, it will describe potential and novel commercial developments in this area. The report will also provide an overview covering major biotechnology and pharma companies involved in developing innovative, targeted breast cancer treatments that address major unmet medical needs to advance cancer care. In addition, the report also provides information regarding the less-developed sectors of this market and presents a list of current companies that have new predictive testing products and drugs in development for breast cancer.

SCOPE AND FORMAT

This report will provide an update and on overview on predictive testing in breast cancer diagnostics and drug technologies and global markets. The study’s objective is to review the tumor marker-based predictive companion tests and drugs for breast cancer, and then assess their global growth potential over a five-year period from 2011 to 2016. Review includes global markets for breast cancer incidence, current drugs, new developments, predictive diagnostic tests, market trends and new technologies, and developments and forecast trends for the use of current tests for better diagnosis and prognosis for breast cancer through 2016. Important tests, technologies and developments; market share by drug, test, current products on the market and market share by company or product; and statistical information for types of breast cancer prevalence globally, with special emphasis on the U.S. market, are discussed. The report focuses on tumor marker-based testing that provides vital information about the cancer. These tests can help determine the appropriate medicine and timing of treatment to address the disease most effectively. The report also includes current issues and trends affecting the industry. The report covers products in development, new technologies, trends, alliances, patents and mergers. It offers market data with respect to segments and geography. Other breast cancer detection and screening technologies and markets (e.g., mammography, ultrasound, biopsy) are not included in this report.

INTENDED AUDIENCE

This report is an exhaustive study on the global breast cancer market, giving crucial statistics and analysis on existing drugs, diagnostic technologies, latest trends, market structure, market size, key drug segments, important trends in technology development, major opportunities and market shares of key players and drugs. This information may prove crucial for the firms or investors seeking opportunities in the concerned sector. This report shows tests currently being used for breast cancer diagnosis and prognosis, new developments, spending trends and revenue prospects for these technologies. It provides market data for 2010 to 2016, and also covers commercial prospects for breast cancer diagnostic and prognostic assays.

METHODOLOGY

Both primary and secondary research methodologies were used in preparing this report. Secondary sources include books, newspapers, trade journals, white papers, industry portals, government agencies, trade associations, industry news, and paid and free databases. The base year of the report is 2010, with forecast data provided through 2016. Historical, base year and forecast data are provided for each market segment of this report.

The report provides a comprehensive review of breast cancer incidence, development of the disease, drugs currently used and diagnostic technologies based on tumor markers for accurate diagnosis and aid in deciding treatment plans for patients. The new analysis reviews technological developments, product innovations and introductions, and recent strategic industry activity of major players across various product categories. Growth rates, global incidence and projections are determined through a compilation of data, including past trends, future trends, demographics, incidence, mortality, products in R&D and current product growth. A comprehensive and exhaustive search of the literature on breast cancer assay development and already–marketed products, breast cancer global incidence and latest drug developments was conducted. These secondary sources included scientific-related journals and articles, textbooks, press releases, marketing literature, other product or promotional literature, annual reports and security analyst reports. Patent searches and analyses were also conducted. Some informal interviews were also conducted with experts and personnel in this area at biotech and pharmaceutical companies. Other resources included academic, technology transfer offices and consulting companies.

ANALYST CREDENTIALSUsha Nagavarapu is a pharmaceutical professional with experience in scientific and alliance development. This includes more than 10 years of drug and device product development and alliance management experience. She has managed preclinical discovery programs from target identification through design of Phase I testing, including IND enabling studies, and assisted out-licensing and portfolio development activities. Strong focus areas include oncology, dermatology and cardiovascular diseases. She has extensive experience working with early-start-ups to fulfill operational obligations while minimizing overall operational cost and burden.

BCC ON-LINE SERVICES

BCC Research offers an online information retrieval service. Its home page, located at www.bccresearch.com, enables readers to:Examine the complete BCC Research catalog of market research reports and place direct orders.Subscribe to any of BCC Research’s many industry newsletters.Read announcements of recently published reports and newly launched newsletters.Register for its well-known conferences.Request additional information on any BCC research product.Take advantage of special offers.

DISCLAIMER

The information developed in this report is intended to be as reliable as possible at the time of publication and of a professional nature. This information does not constitute managerial, legal or accounting advice, nor should it serve as a corporate policy guide, laboratory manual or an endorsement of any product, as much of the information is of a speculative in nature. The author assumes no responsibility for any loss or damage that might result from reliance on the reported information or from its use.

This strategic C-level research aims at providing an overview of key trends and tectonic shifts that are expected to take place in the oil and gas market. We have considered only the upstream or exploration and production for this research and this research focuses on what are the major game changers of the future and how the geopolitical alignment is driven by the need to have better energy security and balance. The research also outlines key aspects of technology innovations and sustainability that are vital in exploring the lesser known unconventional resources of the world.

Idea Labs Industry Scorecard Oil and Gas: Scope OverviewThis scorecard will analyze only the production, exploration, and pipeline management activities of the Oil and Gas industry.Refining and downstream activities are not included.Actionable insights are provided for each issue-based analysis.Automation opportunities in the Oil and Gas industry will be the subsequent study in this series.

Oil ProductionGlobal Offshore Growth Prospects: East Dominates on Reserves, but Depends on West for Technology and InnovationBrazil's Deepwater Pre-Salt Finds and Global Partnerships likely to Position it in the Top 5 Oil Producing Countries of the World by 2030Malaysia to Become Asia-Pacific’s Deepwater (DW) and Oilfield Service and Equipment (OFSE) Hub: At Stake, is an Investment of at Least $200.00 Billion by 2020Canada’s Dirty Oil to Increase Adoption Rate of Clean Technology and thus Attract Investment of $218.00 billionNational Oil Company’s (NOC) Rise in Global Importance Requires at Least $5.0 Trillion Investment to Control Reserves by 2030

Gas ProductionTechnology Robustness and Substantial Shale Reserves May Supplant the U.S. Gas Imports by 2030Global Shale Gas Challenge Alters Geopolitics through Technological Exchange StrategiesExisting LNG infrastructure in Qatar to Accommodate Short Term Increase in Exports while Opening Up Opportunities in Operation and Maintenance ServicesSouth Korea’s Energy Security Efforts Opens up Infrastructural Opportunities, while Domestic Experience Drives Local EPC Firms International DominanceEurope’s Increasing Natural Gas Consumption to Hike Supplies from Middle East and Africa, While Promoting Domestic Increase in Renewable Energy

Future Perspectives

A CEO 360 Perspective

AppendixTerms and DefinitionAppendix for OffshoreAppendix for Brazil Pre-saltAppendix for Canada’s Dirty OilAppendix for Shale in the United StatesAppendix for Shale outside the United StatesAppendix for QatarAppendix for Europe’s Gas Imports

This research covers the global marketing process optimization solutions market. Frost & Sullivan defines the MPOS market as a value chain of product suites that offer marketing departments the ability to execute marketing functions including: planning, creation of print and digital marketing collateral, campaign and workflow management, benchmarking, marketing automation, analytics, and social media integration. Growth by region is forecasted, and demand analysis by industry vertical is provided. An analysis of the competitive structure including vendors' market shares is performed, and detailed profiles of the key vendors are outlined. The base year is 2010 with forecasts through 2017.